mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.47 |
0.002 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.004 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.007 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |